Aptus Capital Advisors, LLC Amgen Inc Transaction History

Aptus Capital Advisors, LLC

$4.95 Billion
Q1 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 17,549 shares of AMGN stock, worth $5.43 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

17,549

Previous 19,528 10.13%

Holding current value

$5.43 Million

Previous $5.62 Million 11.29%

% of portfolio

0.1%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $532,093 - $642,304	-1,979 Reduced 10.13%	17,549 $4.99 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $511 - $576	2 Added 0.01%	19,528 $5.62 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $53,131 - $65,964	-243 Reduced 1.23%	19,526 $5.25 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $3.79 Million - $4.48 Million	17,683 Added 847.7%	19,769 $4.39 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $2.35 Million - $2.86 Million	-10,391 Reduced 83.28%	2,086 $504,000

Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2.36 Million - $3 Million	10,325 Added 479.79%	12,477 $3.28 Million
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $6,509 - $7,341	-29 Reduced 1.33%	2,152 $485,000
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $43,834 - $48,780	190 Added 9.54%	2,181 $531,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $217,954 - $241,114	994 Added 99.7%	1,991 $481,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $1.82 Million - $2.09 Million	-9,163 Reduced 90.19%	997 $224,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $1.46 Million - $1.71 Million	-6,887 Reduced 40.4%	10,160 $2.16 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $326,778 - $362,536	1,399 Added 8.94%	17,047 $4.16 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $5,547 - $6,465	25 Added 0.16%	15,648 $3.89 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $529,481 - $630,518	2,447 Added 18.57%	15,623 $3.59 Million
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $102,776 - $114,296	438 Added 3.44%	13,176 $3.35 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $208,096 - $255,362	1,052 Added 9.0%	12,738 $3 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $259,874 - $344,664	1,426 Added 13.9%	11,686 $2.37 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $447,860 - $575,654	2,367 Added 29.99%	10,260 $2.47 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $94,715 - $113,489	-544 Reduced 6.45%	7,893 $1.53 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $14,336 - $16,805	86 Added 1.03%	8,437 $1.55 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $14,288 - $16,106	79 Added 0.96%	8,351 $1.59 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.48 Million - $1.72 Million	8,272 New	8,272 $1.61 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Amgen Inc Transaction History